FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783503229> ?p ?o ?g. }

• W2783503229 abstract "Objective: To assess the feasibility of conducting an adolescent migraine prevention trial of melatonin predominantly via the internet. Background: Adolescent migraine is common, yet few migraine preventive therapies have been studied in this age group. Melatonin is safe and effective for migraine prevention in adults. We conducted a randomized trial in which most of the procedures were performed from the convenience of the participants’ homes. Design/Methods: Adolescents (12–17 y.o.) with 2–24 migraine days/month were recruited and screened using online advertising and targeted invitations. Following a one-time in-person enrollment visit, participants completed a 28-day baseline headache diary on their smartphones. Subjects who met randomization criteria were randomized 1:1 to melatonin 3 mg or placebo for 12-weeks. The enrollment goal was 30 participants. Results: Thirty-one participants were enrolled at a single site, and 26 met randomization criteria (n=13 per group). Baseline characteristics were comparable except for a higher mean PedMIDAS score in the melatonin group: 51±29 vs. 31±28, p=0.04. Baseline mean migraine days/month were similar: 6.4±4.6 (placebo) vs. 5.6±3.2 (melatonin). Outcome data were available for 23/26 (89%). In the third month of treatment, mean migraine days/month was: 4.9±5.5 (placebo) vs. 3.6±3.0 in the melatonin group (p=0.83, delta −1.3 days). In a secondary analysis adjusted for baseline PedMIDAS score, mean migraine days/month in the melatonin group was −2.3 days lower than in the placebo group (95% CI −6.3 to 1.8, p=0.25). There were no serious adverse events. One participant in the melatonin group stopped study drug due to daytime tiredness. Estimates of efficacy and variance in our main endpoint measurements indicate that an efficacy trial would require outcome data on 42 participants/arm. Conclusions: It is feasible to conduct a migraine preventive trial in adolescents via the internet. These preliminary data suggest that melatonin may reduce the frequency of adolescent migraine and inform design of a fully-powered internet-based trial. Study Supported by: UCSF CTSI, NIH/NCATS TR001870-01, the Migraine Research Foundation, the Irene Perstein Award and an anonymous family philanthropic donation. Disclosure: Dr. Gelfand has received personal compensation for activities with for Eli Lilly, Zosano, and Teva as a consultant and for travel expenses. Dr. Gelfand has received research suppor from eNeura, EMKinetics, and Allergan. Dr. Qubty has nothing to disclose. Dr. Patniyot has nothing to disclose. Dr. Pletcher has received research support from ZOLL. Dr. Goadsby has received personal compensation for activities with Allergan, eNeura, Autonomic Technologies Inc, Amgen, AlderBio, Pfizer, DrReddy, Zosano, Colucid, Eli Lilly, Avanir, Gore,Heptares, Nupathe, Teva, Cipla, Ajinomoto, Akita,Wells Fargo, Ethicon,Promius. Dr. Goadsby has received personal compensation in an editorial capacity for JournalWatch Neurology and UptoDate. Dr. Goadsby has received research supporting from Amgen, eNeura, Allergan. Dr. Cummings has received personal compensation for activities with Lilly, Merck, Radius, Amgen, Inc., Sermonix, Regeneron, Calico, Grail, and Google Research." @default.
• W2783503229 created "2018-01-26" @default.
• W2783503229 creator A5004525209 @default.
• W2783503229 creator A5011978959 @default.
• W2783503229 creator A5023069032 @default.
• W2783503229 creator A5034447689 @default.
• W2783503229 creator A5076177073 @default.
• W2783503229 creator A5087434494 @default.
• W2783503229 date "2017-04-18" @default.
• W2783503229 modified "2023-09-28" @default.
• W2783503229 title "Melatonin for Adolescent Migraine Prevention: A Pilot Internet-based Randomized Controlled Trial (P2.163)" @default.
• W2783503229 hasPublicationYear "2017" @default.
• W2783503229 type Work @default.
• W2783503229 sameAs 2783503229 @default.
• W2783503229 citedByCount "0" @default.
• W2783503229 crossrefType "journal-article" @default.
• W2783503229 hasAuthorship W2783503229A5004525209 @default.
• W2783503229 hasAuthorship W2783503229A5011978959 @default.
• W2783503229 hasAuthorship W2783503229A5023069032 @default.
• W2783503229 hasAuthorship W2783503229A5034447689 @default.
• W2783503229 hasAuthorship W2783503229A5076177073 @default.
• W2783503229 hasAuthorship W2783503229A5087434494 @default.
• W2783503229 hasConcept C126322002 @default.
• W2783503229 hasConcept C142724271 @default.
• W2783503229 hasConcept C168563851 @default.
• W2783503229 hasConcept C1862650 @default.
• W2783503229 hasConcept C204243189 @default.
• W2783503229 hasConcept C204787440 @default.
• W2783503229 hasConcept C27081682 @default.
• W2783503229 hasConcept C2778182776 @default.
• W2783503229 hasConcept C2778541695 @default.
• W2783503229 hasConcept C71924100 @default.
• W2783503229 hasConceptScore W2783503229C126322002 @default.
• W2783503229 hasConceptScore W2783503229C142724271 @default.
• W2783503229 hasConceptScore W2783503229C168563851 @default.
• W2783503229 hasConceptScore W2783503229C1862650 @default.
• W2783503229 hasConceptScore W2783503229C204243189 @default.
• W2783503229 hasConceptScore W2783503229C204787440 @default.
• W2783503229 hasConceptScore W2783503229C27081682 @default.
• W2783503229 hasConceptScore W2783503229C2778182776 @default.
• W2783503229 hasConceptScore W2783503229C2778541695 @default.
• W2783503229 hasConceptScore W2783503229C71924100 @default.
• W2783503229 hasLocation W27835032291 @default.
• W2783503229 hasOpenAccess W2783503229 @default.
• W2783503229 hasPrimaryLocation W27835032291 @default.
• W2783503229 hasRelatedWork W2587495866 @default.
• W2783503229 hasRelatedWork W2801706337 @default.
• W2783503229 hasRelatedWork W2802731780 @default.
• W2783503229 hasRelatedWork W2804412694 @default.
• W2783503229 hasRelatedWork W2808054523 @default.
• W2783503229 hasRelatedWork W2808059846 @default.
• W2783503229 hasRelatedWork W2866875357 @default.
• W2783503229 hasRelatedWork W2885303563 @default.
• W2783503229 hasRelatedWork W2888223345 @default.
• W2783503229 hasRelatedWork W2893281143 @default.
• W2783503229 hasRelatedWork W2899764244 @default.
• W2783503229 hasRelatedWork W2902379087 @default.
• W2783503229 hasRelatedWork W2955989092 @default.
• W2783503229 hasRelatedWork W3043068731 @default.
• W2783503229 hasRelatedWork W3086841210 @default.
• W2783503229 hasRelatedWork W3139500862 @default.
• W2783503229 hasRelatedWork W3159653795 @default.
• W2783503229 hasRelatedWork W3166898492 @default.
• W2783503229 hasRelatedWork W3185129165 @default.
• W2783503229 hasRelatedWork W3189627156 @default.
• W2783503229 hasVolume "88" @default.
• W2783503229 isParatext "false" @default.
• W2783503229 isRetracted "false" @default.
• W2783503229 magId "2783503229" @default.
• W2783503229 workType "article" @default.